2026/0085 - Invitation for Proposals under Framework Agreements 2023/671, 2023/304, 2023/437, 2023/490, 2023/491, 2024/780, 2024/900, 2025/1303, and 2025/1428 for the Acquisition of Medicines

This tender is an invitation for proposals related to the procurement of medicines. It operates under a framework agreement system, referencing multiple existing framework agreements with specific codes: 2023/671, 2023/304, 2023/437, 2023/490, 2023/491, 2024/780, 2024/900, 2025/1303, and 2025/1428. The tender, identified by the number 2026/0085, seeks to solicit bids from eligible suppliers for the supply of various medicinal products. The use of framework agreements suggests that pre-qualified suppliers have already been selected through a prior competitive process, and this invitation is to draw specific supplies from these established agreements. This approach streamlines the procurement process for commonly purchased items like medicines, ensuring availability and potentially better pricing through negotiated terms. The scope of medicines covered is broad, as indicated by the multiple framework agreements, likely encompassing a wide range of therapeutic categories. The procurement is scheduled for the year 2026, indicating a need for ongoing supply of these essential pharmaceutical products.

This is a supplies contract in the health and medical services, information and communication technology and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 249,608.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.